Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Cancer. 2023 Mar 23;129(13):2004–2012. doi: 10.1002/cncr.34753

Table 1:

Patient characteristics

Characteristic No. of patients (%)
N = 50
Median age at diagnosis, years (IQR) 53 (42, 64)
Race
 White 39 (78%)
 Black or African American 3 (6%)
 Asian 6 (12%)
 Unknown 2 (4 %)
Median BMI at diagnosis, kg/m2 (IQR) 25 (22, 29)
Stage at diagnosis
 III 39 (78%)
 IV 11 (22%)
KRAS profiling
KRAS wild type 24 (80%)
KRAS mutation 6 (20%)
 Unknown 20
Postoperative residual tumor
 Complete gross resection 26 (55%)
 Optimal (≤1 cm) 14 (30%)
 Suboptimal (>1 cm) 7 (15%)
 No surgery/unknown 3
Surgical procedure performed beyond standard staging *
 Bowel resections 24 (50%)
 Upper abdominal procedures 21 (44%)
 Major urologic procedures 2 (4%)

IQR, interquartile range; BMI, body mass index

*

Denominator is patients who underwent surgery, n=48